Clinical Trial

Efficacy and Safety of a New Sperm Capacitation Method

Study acronym: HyperSperm01
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Prospective, multicenter research study with a split-sample design on semen samples, without intervention, to evaluate the efficacy and safety of HyperSperm, a new sperm capacitation method, in 300 semen samples with various characteristics and abnormalities, in an in vitro study over 12 months.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-12-16; most recent amendment 2026-02-24.
Status change: Not Yet Recruiting → Recruiting 2025-01-15
Trial Details
NCT Number NCT06742437
Lead Sponsor Fecundis Lab SL
Conditions Reproductive Issues, Male Infertility, Asthenozoospermia, Oligozoospermia, Teratozoospermia
Enrollment 300 participants
Start Date 2025-01-14
Primary Completion 2026-06 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2026-02-27